Surgical Correction of Severe Dystrophic Cervical Kyphosis With Intraoperative Motor-Evoked Potential Changes in a Pediatric Patient With Neurofibromatosis Type 1

  • International Journal of Spine Surgery
  • September 2026,
  • 8958;
  • DOI: https://doi.org/10.14444/8958

Abstract

We report a rare case of severe dystrophic cervical kyphosis associated with neurofibromatosis type 1 (NF-1) and highlight the importance of intraoperative neuromonitoring. A 4-year-old girl with café-au-lait spots was diagnosed with NF-1. At age 5 years, she presented with posterior neck protrusion without neurological deficits. Radiographs revealed progressive cervical kyphosis measuring 87° from C2 to C6. One year later, she developed upper limb weakness and gait disturbance. Magnetic resonance imaging demonstrated severe spinal canal stenosis at the C4/C5 level. Posterior instrumentation from the occiput to T2 was performed under intraoperative motor-evoked potential (MEP) monitoring. A significant decrease in MEP signals was observed after final fixation. Removal of lateral mass screws at C3 and C4 and decompression from C2 to C5 resulted in recovery of MEP signals. Anterior spinal fusion from C3 to C7 using an autologous fibular graft was subsequently performed. Postoperatively, cervical kyphosis improved from 87° to 26°, and the patient showed complete neurological recovery at 6 months. Solid bony fusion was confirmed at 8 months. Selumetinib therapy was initiated for unresectable plexiform neurofibromas, resulting in tumor reduction. This case highlights the surgical challenges of dystrophic cervical kyphosis in NF-1 and underscores the critical role of intraoperative neuromonitoring in preventing irreversible neurological injury.

Introduction

Neurofibromatosis type 1 (NF-1) is an autosomal dominant genetic disorder often associated with skeletal abnormalities, including scoliosis and cervical kyphosis.1–4 Dystrophic cervical kyphosis in NF-1 can result in severe apical vertebral wedging, vertebral scalloping, and neurological complications.5–9 Surgical treatment requires high technical proficiency due to bone instability and the risk of rapid neurological deterioration. Early surgical intervention is recommended in such cases.5,9

We report the case of a 4-year-old girl with progressive cervical kyphosis associated with NF-1, treated with anterior spinal fusion using an autologous fibular bone graft. Eight months postoperatively, imaging confirmed bony fusion. The patient was subsequently treated with Selumetinib, which was effective in reducing the size of plexiform neurofibromas.

Case Report

Medical History

A 4-year-old girl with a history of café-au-lait spots was diagnosed with NF-1. At age 5, she presented to our pediatric orthopedic department with posterior neck protrusion. She had no neurological symptoms at the time. Radiographs showed progressive cervical kyphosis measuring 87° from C2 to C6 (Figure 1).

Figure 1

Wedge-shaped deformity of the C3–C5 vertebral bodies with a kyphotic angle of 87°. No obvious scoliosis observed.

One year later, at age 6, she developed upper limb muscle weakness and gait disturbance. Magnetic resonance imaging revealed severe spinal canal stenosis and kyphosis at the C4/C5 level.

Physical and Neurological Examination

After a fall from a height of 1 meter, neurological symptoms worsened. Muscle weakness developed in both upper limbs. Manual muscle testing showed a grade of 1 in the left deltoid, biceps, and triceps. Deep tendon reflexes (Achilles and patellar) were increased on the left, and Babinski reflexes were positive bilaterally.

Laboratory Findings

Complete blood count and C-reactive protein levels were within normal limits, with no signs of systemic inflammation.

Radiological Findings

Preoperative computed tomography showed severe kyphotic change with thinning of laminae and pedicles from C4 to C7. Initial T2-weighted magnetic resonance imaging revealed diastematomyelia at the C3/C4 level and plexiform neurofibromas at the bilateral brachial plexus and thoracic apex (Figure 2). Dynamic x-ray images demonstrated limited cervical range of motion, which improved under general anesthesia and skull traction. Motor-evoked potential (MEP) monitoring showed no deterioration during this time (Figure 3).

Figure 2

Preoperative computed tomography (CT) showed severe kyphotic change with thinning of laminae and pedicles from C4 to C7. Preoperative magnetic resonance imaging (MRI) showed deformed vertebral bodies compressing the spinal cord (black arrow) and plexiform neurofibromas at the bilateral brachial plexus and thoracic apex (white arrows).

Figure 3

Cervical mobility and motor-evoked potential (MEP) monitoring under general anesthesia. MEP monitoring showed no deterioration under cervical motion in extension and neutral positions.

Diagnosis and Treatment

Posterior instrumentation from occiput to T2 was performed using skull traction. Intraoperatively, a significant decrease in MEPs was observed in both upper and lower extremities after final fixation. MEP signals recovered following the removal of lateral mass screws at C3 and C4 and laminectomy from C2 to C5 (Figure 4). Anterior spinal fusion from C3 to C7 was then performed using an autologous fibular bone graft.

Figure 4

A significant decrease in motor-evoked potentials (MEPs) was observed after posterior fixation. MEP signals recovered following the removal of lateral mass screws at C3 and C4 and laminectomy from C2 to C5.

Postoperative Course

Kyphosis was corrected from 87° to 26°. A halo vest was applied for 7 weeks. Six months postoperatively, the patient had fully recovered neurologically. Eight months after surgery, x-ray and computed tomography confirmed solid bony fusion (Figure 5). She then began Selumetinib treatment for plexiform neurofibromas; the treatment was well tolerated with careful monitoring for adverse effects.

Figure 5

Eight months after surgery, x-ray and computed tomography images confirmed solid bony fusion.

Discussion

Dystrophic cervical kyphosis is a rare but potentially devastating spinal manifestation of NF-1. Although spinal deformities are relatively common in patients with NF-1, severe dystrophic deformity involving the cervical spine is uncommon, and the available literature remains limited.1–5,8–11 Dystrophic changes, including vertebral wedging and scalloping, enlargement of the neural foramina, and thinning or dysplasia of the pedicles and posterior elements, may lead to rapid progression of kyphosis, instability, and neurological compromise.3–5,8–11 These characteristics are particularly concerning in young children, in whom progression of the deformity may continue during growth.4,10

Management of severe dystrophic cervical kyphosis in NF-1 remains challenging. Conservative treatment, including bracing, is generally ineffective for progressive dystrophic deformities, and surgical stabilization is often required when severe or progressive kyphosis or neurological impairment is present.4,5,8–11 However, poor bone quality, dysplastic vertebrae, deficient posterior elements, severe deformity, and associated neurofibromas can complicate instrumentation and achievement of solid fusion.3–11 Furthermore, pseudarthrosis, loss of correction, progression of vertebral dysplasia, instrumentation failure, and neurological complications remain important concerns after surgical treatment.5,8–11

The optimal surgical approach remains controversial. Combined anterior and posterior fusion has traditionally been advocated for severe dystrophic cervical kyphosis because it can provide circumferential stability and promote solid fusion.5–11 Helenius et al reported 22 children with NF-1-associated cervical kyphosis and found significantly greater correction following combined anteroposterior surgery than following posterior-only fusion (83% vs 58%).10 However, complications occurred in 13 of the 22 patients, including 5 new neurological deficits, and 9 patients required revision surgery.10 Lin et al compared anterior-only, posterior-only, and anteroposterior approaches in 81 patients and reported that the anteroposterior approach provided the greatest correction of dystrophic cervical kyphosis and sagittal alignment.9 More recently, a systematic review of 124 patients found that combined anterior-posterior surgery generally achieved greater deformity correction than single-approach procedures, although the combined approach was associated with greater surgical risk.11 Therefore, the surgical strategy should be individualized according to the severity and rigidity of the deformity, the extent of dystrophic changes, neurological status, and the location of associated neurofibromas.

Achieving reliable spinal fusion is another major challenge in NF-1-associated dystrophic cervical kyphosis. Fibular grafting has been used to provide structural anterior support in severe deformities.6–8 Kumagai et al reported 2 patients treated with anterior fusion using vascularized fibular grafts with favorable long-term outcomes,6 while Kakuta et al described circumferential fusion using an autologous vascularized free fibula for severe NF-1-associated cervical kyphosis.7 Kawabata et al also reported surgical correction of severe cervical kyphosis using combined reconstruction.8 In the present patient, anterior fusion from C3 to C7 using an autologous fibular graft following posterior instrumentation resulted in correction of the kyphosis from 87° to 26°, and solid bony fusion was confirmed 8 months postoperatively.

Intraoperative neuromonitoring was particularly important in the present case. Although MEP signals remained stable during cervical motion under general anesthesia and skull traction, a significant decrease in MEPs in both the upper and lower extremities occurred following final posterior fixation. Removal of the C3 and C4 lateral mass screws and decompression from C2 to C5 resulted in recovery of the MEP signals. This event suggests that even when preoperative traction and intraoperative positioning are neurologically tolerated, correction and instrumentation of a severely dystrophic cervical spine may produce acute spinal cord compromise. Given the substantial risk of neurological complications reported in previous surgical series,5,8–11 intraoperative MEP monitoring can serve not only as a means of detecting neurological injury but also as a real-time guide for modifying the surgical strategy before irreversible neurological damage occurs.

NF-1 further complicates long-term management because of the presence and potential progression of plexiform neurofibromas.12–16 Surgical resection may be difficult or impossible depending on the location and extent of the tumor.12,13 In the present patient, unresectable plexiform neurofibromas were present at the bilateral brachial plexus and thoracic apex. Selumetinib, a MEK inhibitor, has demonstrated efficacy in children with symptomatic, inoperable NF-1-associated plexiform neurofibromas.17,18 Following confirmation of spinal fusion, selumetinib therapy was initiated and resulted in tumor reduction. Long-term multidisciplinary follow-up is therefore important not only for maintenance of spinal alignment and fusion but also for management of the underlying manifestations of NF-1.

This case illustrates that severe dystrophic cervical kyphosis in a young child with NF-1 requires an individualized and multidisciplinary treatment strategy. Combined anterior and posterior stabilization can provide substantial deformity correction and solid fusion, but the high neurological risk associated with correction of a severely dystrophic cervical spine should be recognized. In particular, the reversible intraoperative MEP deterioration observed in this patient highlights the value of continuous neuromonitoring and immediate modification of the surgical procedure when neurological compromise is detected.

Conclusion

This case highlights the challenges of managing severe cervical kyphosis in pediatric NF-1 patients. A combination of anterior and posterior surgical approaches, along with vigilant intraoperative monitoring and long-term pharmacologic therapy with Selumetinib, contributed to a successful outcome.

Footnotes

  • Funding The authors received no financial support for the research, authorship, and/or publication of this article.

  • Declaration of Conflicting Interests The authors report no conflicts of interest in this work.

References

  1. 1.
    ↵
    Winter RB, Moe JH, Bradford DS, Lonstein JE, Pedras CV, Weber AH. Spine deformity in neurofibromatosis. a review of one hundred and two patients. J Bone Joint Surg Am. 1979;61(5):677–694.
  2. 2.
    ↵
    Akbarnia BA, Gabriel KR, Beckman E, Chalk D. Prevalence of scoliosis in neurofibromatosis. Spine (Phila Pa 1976). 1992;17(8 Suppl):S244–S248. 10.1097/00007632-199208001-00005
  3. 3.
    ↵
    Funasaki H, Winter RB, Lonstein JB, Denis F. Pathophysiology of spinal deformities in neurofibromatosis. An analysis of seventy-one patients who had curves associated with dystrophic changes. J Bone Joint Surg Am. 1994;76(5):692–700. 10.2106/00004623-199405000-00010
  4. 4.
    ↵
    Sirois JL, Drennan JC. Dystrophic spinal deformity in neurofibromatosis. J Pediatr Orthop. 1990;10(4):522–526. 10.1097/01241398-199010040-00019
  5. 5.
    ↵
    Wang J, Liu C, Wang C, et al. Early and midterm outcomes of surgical correction for severe dystrophic cervical kyphosis in patients with neurofibromatosis type 1: a retrospective multicenter study. World Neurosurg. 2019;127:e1190–e1200. 10.1016/j.wneu.2019.04.096
  6. 6.
    ↵
    Kumagai G, Echigoya N, Wada K, Asari T, Toh S, Ishibashi Y. Anterior fusion using a vascularized fibular graft for cervical kyphosis associated with neurofibromatosis type 1: a report of two cases with long-term follow-up. J Orthop Case Rep. 2021;11(1):97–100. 10.13107/jocr.2021.v11.i01.1980
  7. 7.
    ↵
    Kakuta Y, Iizuka Y, Mieda T, Takasawa E, Chikuda H. Cervical kyphosis due to neurofibromatosis type 1 treated by circumferential spinal fusion using an autologous vascularized free fibula followed by teriparatide administration: a case report. J Orthop Case Rep. 2022;12(7):98–101. 10.13107/jocr.2022.v12.i07.2934
  8. 8.
    ↵
    Kawabata S, Watanabe K, Hosogane N, et al. Surgical correction of severe cervical kyphosis in patients with neurofibromatosis type 1. J Neurosurg Spine. 2013;18(3):274–279. 10.3171/2012.11.SPINE12417
  9. 9.
    ↵
    Lin T, Shao W, Zhang K, Gao R, Zhou X. Comparison of outcomes in 3 surgical approaches for dystrophic cervical kyphosis in patients with neurofibromatosis 1. World Neurosurg. 2018;111:e62–e71. 10.1016/j.wneu.2017.11.174
  10. 10.
    ↵
    Helenius IJ, Sponseller PD, Mackenzie W, et al. Outcomes of spinal fusion for cervical kyphosis in children with neurofibromatosis. J Bone Joint Surg Am. 2016;98(21):e95. 10.2106/JBJS.16.00096
  11. 11.
    ↵
    Ananda DGP, Dwipajaya IBS, Antara IBAV, Irayati N, Fauzi AA. Outcomes of surgical intervention of dystrophic cervical kyphosis in patients with neurofibromatosis type 1: a systematic review. Spine Surg Relat Res. 2026;10(1):11–18. 10.22603/ssrr.2025-0061
  12. 12.
    ↵
    Iheanacho I, Yoo HK, Yang X, Dodman S, Hughes R, Amin S. Epidemiological and clinical burden associated with plexiform neurofibromas in pediatric neurofibromatosis type-1 (NF-1): a systematic literature review. Neurol Sci. 2022;43(2):1281–1293. 10.1007/s10072-021-05361-5
  13. 13.
    ↵
    Farmer J-P, Khan S, Khan A, et al. Neurofibromatosis type 1 and the pediatric neurosurgeon: a 20-year institutional review. Pediatr Neurosurg. 2002;37(3):122–136. 10.1159/000064398
  14. 14.
    ↵
    Mautner VF, Hartmann M, Kluwe L, Friedrich RE, Fünsterer C. MRI growth patterns of plexiform neurofibromas in patients with neurofibromatosis type 1. Neuroradiology. 2006;48(3):160–165. 10.1007/s00234-005-0033-4
  15. 15.
    ↵
    Nguyen R, Dombi E, Widemann BC, et al. Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1. Orphanet J Rare Dis. 2012;7:75. 10.1186/1750-1172-7-75
  16. 16.
    ↵
    Dombi E, Solomon J, Gillespie AJ, et al. NF1 plexiform neurofibroma growth rate by volumetric MRI: relationship to age and body weight. Neurology. 2007;68(9):643–647. 10.1212/01.wnl.0000250332.89420.e6
  17. 17.
    ↵
    Gross AM, Wolters PL, Dombi E, et al. Selumetinib in children with inoperable plexiform neurofibromas. N Engl J Med. 2020;382(15):1430–1442. 10.1056/NEJMoa1912735
  18. 18.
    ↵
    Dombi E, Baldwin A, Marcus LJ, et al. Activity of selumetinib in neurofibromatosis type 1-related plexiform neurofibromas. N Engl J Med. 2016;375(26):2550–2560. 10.1056/NEJMoa1605943
View Abstract
Loading
Loading